Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs now tops 50%. Notably, Lilly's market share is increasing while Novo ...